Spectral AI Collaborates with PolyNovo to Introduce DeepView System for Burn Treatment in Australia

Tuesday, July 09, 2024

Spectral AI, an AI company focused on improving medical diagnostics in wound care, announced it has signed a Memorandum of Understanding (MOU) with PolyNovo Limited, a global leader in burn wound therapy.

This collaboration aims to support the limited deployment of Spectral AI's DeepView™ System for burn treatment in Australia.

Under the MOU, PolyNovo will assist Spectral AI in applying to the Australian Special Access Scheme (SAS).

The objective is to deploy up to two DeepView™ Systems at the Royal Adelaide Hospital and The Alfred Hospital in Melbourne. This will help prepare for a broader commercial roll-out based on feedback from clinicians.

The SAS, established by Australia's Therapeutics Goods Administration, allows patients to access certain medicines, medical devices, or biologics not yet included in the Australian Register of Therapeutic Goods.

The DeepView™ System is a predictive device that gives clinicians a quick and objective assessment of a burn wound’s healing potential before treatment.

It uses an image processing algorithm with multispectral imaging, backed by a database of over 340 billion clinically validated data points.

The system is non-invasive and cart-based for easy mobility within healthcare facilities.

PolyNovo specializes in patented, bioabsorbable synthetic polymer technology for reconstructing complex wounds, including deep dermal and full-thickness burns, and supporting new tissue growth.

Their FDA-approved NovoSorb® BTM (Biodegradable Temporising Matrix) and NovoSorb® MTX products are available in 37 countries.

"PolyNovo’s therapies are transformative, making it a highly respected provider of burn treatment solutions."

"Knowing when to apply these therapies is crucial for better patient outcomes. The Day One wound healing assessment from the DeepView™ System gives clinicians the information they need for quick and informed decisions.

We are proud to partner with PolyNovo to introduce our technology to Australian clinicians, support their vital work, and improve patient care."





Source: spectral-ai.com